SBIR Phase II: Exploring Complex Biological Concepts in an Interactive 3-D Learning Environment over the Internet

这个小型企业创新研究第二阶段项目将创建一个3D交互式学习系统，以传达生物和医学科学中复杂的科学概念，这些概念很难通过长时间的叙述性脚本来掌握。 在第一阶段制定的详细技术规格将发展成为一个软件解决方案，有别于目前的解决方案。 这个学习工具允许用户在可视化环境中查询对象，在可视化环境中可以操纵这些对象的特定方面。 Syandus采用了视频游戏常见的复杂实时3D渲染技术，具体如下：1）通过创建与时间驱动的复杂科学现象的3D过程模型交互的能力; 2）通过将文本信息与这些可视化对象和过程相关联。 在用户的鼠标点击，对象智能地揭示了他们是关于深层次的文本，插图和链接文件。 这个界面可以聚合所有类型的信息，例如制药公司关于某种疾病的所有技术信息。 最后，Syandus正在开发一种软件，该软件将通过标准浏览器界面在互联网上发布，或者从CDROM启动，并通过窄带互联网连接自动更新。 药品之间的差异越来越多地建立在快速发展的复杂科学的基础上，因此必须有一种机制来汇总和交流与药物如何作用于疾病状态有关的科学信息。 Syandus专注于制药行业作为公司的第一个目标市场，建议创建一个工具，帮助医生了解治疗对人们生活产生不利影响的复杂疾病状态的突破性药物。 该公司的定制项目将为医学生、专业人士和医疗保健消费者提供持久的资源。随着技术的成熟，该公司将进军高等教育市场。 通过互联网连接，该产品可以接触到地球仪的广大受众。

This Small Business Innovation Research Phase II project will create a 3D, interactive learning system to communicate complex scientific concepts from biological and medical science, which are difficult to grasp via long narrative scripts. The detailed technical specifications formulated in Phase I will be developed into a software solution distinctive from what is available today. This learning tool allows the user to inquire about objects in a visualization context, where specific aspects of these objects can be manipulated. Syandus has adapted sophisticated real-time 3D rendering technology common to video games as follows: 1) by creating the ability to interact with time driven, 3D process models of complex scientific phenomena; and 2) by associating textual information with these visualized objects and processes. At a user's mouse click, objects intelligently reveal what they are about in deeply layered text, illustrations and linked files. This interface can aggregate all kinds of information, such as all of a pharmaceutical company's technical information on a disease. Finally, Syandus is building the software to be delivered across the Internet through a standard browser interface or launched from a CDROM and automatically updated via a narrowband Internet connection. The differentiation among pharmaceutical products is ever increasingly grounded in rapidly evolving complex science, thus making essential a mechanism for aggregating and communicating scientific information that relates how drugs work to disease states. Focusing on the pharmaceutical industry as the firm's first target market, Syandus proposes to create a tool to help physicians understand the breakthrough medicines to treat complex disease states that adversely impact people's lives. The firm's custom projects will result in enduring resources for medical students, professionals and healthcare consumers. As the technology matures, the firm will pursue higher education markets. Through Internet connectivity, the product can reach wide audiences across the globe.